Viewing Study NCT00214604


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2025-12-25 @ 7:03 PM
Study NCT ID: NCT00214604
Status: COMPLETED
Last Update Posted: 2010-11-19
First Post: 2005-09-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Type III Dysbetalipoproteinemia
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module